Brief: IX Biopharma Obtains Approval And Registration Of Silcap In Singapore
20/10/2020 02:18
Oct 20 (Reuters) - IX Biopharma Ltd IXBI.SI :
* OBTAINS APPROVAL AND REGISTRATION OF SILCAP IN SINGAPORE
Source text for Eikon: ID:nSNZd3qT0
Further company coverage: IXBI.SI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IX Biopharma
See all newsBrief: Ix Biopharma Confirms Orion Not Yet Obtained Licence From Nevada State Board Of Pharmacy
Brief: Ix Biopharma Says U.S. Govt Opens Emergency Pathway, Clears Path For Wafermine Application For EUA
Brief: IX Biopharma Says Co Will Undertake An Internal Restructuring Of Its Consumer Business
Brief: IX Biopharma To Issue 1 MLN New Shares To Anson Properties At S$0.4215 Per Share
Brief: IX Biopharma Says US Government Awards US$41 MLN Contract To Fund Development Of Wafermine